On this page of StockholderLetter.com we present the latest annual shareholder letter from REPLIGEN CORP — ticker symbol RGEN. Reading current and past RGEN letters to shareholders can bring important insights into the investment thesis.


Inspiring Advances in Bioprocessing In this report, we are highlighting our in bioprocessing through new product buildouts; and rebalancing our resources. these areas and more, despite the macro in bioprocessing . Repligen.com 01

2023 business HIGHLIGHTS Repligen.com repligen.com 08 03
 • shareholder letter icon 4/1/2024 Letter Continued (Full PDF)
 • stockholder letter icon 4/11/2023 RGEN Stockholder Letter
 • stockholder letter icon More "Biotechnology" Category Stockholder Letters
 • Benford's Law Stocks icon RGEN Benford's Law Stock Score = 89


RGEN Shareholder/Stockholder Letter Transcript:



Inspiring Advances in
Bioprocessing
In this report, we are highlighting our

in bioprocessing through new product


buildouts; and rebalancing our resources.
these areas and more, despite the macro

in bioprocessing   .
Repligen.com
01


2023
business
HIGHLIGHTS

Repligen.com
repligen.com
08
03



shareholder letter icon 4/1/2024 Letter Continued (Full PDF)
 

RGEN Stockholder/Shareholder Letter (REPLIGEN CORP) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.